Study to Evaluate the Effectiveness of SGB in Preventing Post-op Atrial Fibrillation
NCT03269383
·
clinicaltrials.gov ↗
PHASE4
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Lack of funding and other logistical issues
Conditions
Atrial Fibrillation
Interventions
DRUG:
Bupivacaine
OTHER:
Saline
Sponsor
Christopher Connors, MD